last published
The United Kingdom (UK) has a mature infrastructure for health data management and genomic integration, with multiple umbrella bodies regulating data sharing and interoperability. Routine NGS implementation and well-established clinical guidelines are in place. However, challenges remain in streamlining cross-border collaborations, optimising molecular diagnostic governance, and ensuring broader clinical adoption
NEWS
Be informed and stay informed on all
news, events and publication updated.
EVENTS
Be informed and stay informed on all
news, events and publication updated.
2–3 September 2025, Club University Foundation in Brussels, visioneurope2030.com The European Alliance for Personalised Medicine (EAPM) is proud to host the upcoming VISION Europe 2030
July 15, 2025 | 12:00–14:00 CET | European Parliament, Brussels Hosted by MEP Seán Kelly Cancer is on track to become the leading cause of
Name: High-level Conference – Fighting Cancer around the World: A Framework for Action Location: Institute of Global Health; University of Geneva, Campus Biotech – G6;
Name: Forward Together with Innovation: The Why, What, and How of Tackling the Implementation Gap for Healthcare in Different Regions Location: Room Las Arenas IV,
Name: The missing element in bringing real innovation to Europe’s healthcare system and tangible benefits for cancer patients Location: Hotel Porta Fira, Pl. d’Europa, 45,
Name: Tackling the implementation gap for the uptake of NGS and advanced molecular diagnostics into healthcare systems: The Role of Pathology and Medical Laboratories Location:
In a world that’s increasingly interconnected and diverse, EAPM is dedicated to spearheading a new era in healthcare — one where precision and personalization redefine the standards of prevention and treatment strategies. Join us in exploring the forefront of medical innovation, where our commitment to individualized care is not just a goal but a revolution.
